Michael Loiacono - 17 Feb 2022 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role
Chief Accounting Officer
Signature
/s/ Michael Loiacono
Issuer symbol
MRKR
Transactions as of
17 Feb 2022
Net transactions value
$0
Form type
4
Filing time
22 Feb 2022, 16:09:06 UTC
Next filing
01 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRKR Employee Stock Option (right to buy) Award $0 +140,000 $0.000000 140,000 17 Feb 2022 Common Stock 140,000 $0.4600 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in equal monthly installments over a four year period commencing on March 17, 2022 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.